Company Overview and News

 
Golden Developing Solutions CEO Issues New Letter to Shareholders

2018-08-22 globenewswire
AUSTIN, Texas, Aug. 22, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Golden Developing Solutions, Inc. (OTCMKTS: DVLP) (“DVLP” or the “Company”), an emerging leader in the CBD Products marketplace, issues the following letter to Shareholders from the CEO:
DVLP ETM.WI ETM

7
Zacks.com featured highlights include: Entercom, Insulet, ESCO and Tristate

2018-08-17 zacks
Chicago, IL – August 17, 2018 - Stocks in this week’s article are Entercom Communications Corp. (ETM - Free Report) , Insulet Corp. (PODD - Free Report) , ESCO Technologies Inc. (ESE - Free Report) and Tristate Capital Holdings, Inc. (TSC - Free Report) .
HD ESE ETM.WI PODD FCCTO BGSF ETM FCCTP FCCO HEAR OXY FIVE TSC FCCT

1
4 Top Stocks With the Power of Earnings Acceleration

2018-08-16 zacks
Take a company’s revenues over a given period of time, subtract the cost of production and you will have its earnings! Right from the top brass to research analysts, earnings growth interests every single one. This is because upbeat earnings serve as an indicator of a company’s profitability. It also more often than not leads to an uptick in the share price.
ESE ETM.WI PODD TSC ETM

10
Meredith (MDP) Q4 Earnings Miss, Revenues In Line, Stock Down

2018-08-13 zacks
Meredith Corporation (MDP - Free Report) reported an earnings miss in fourth-quarter fiscal 2018 after four straight quarters of beat. The bottom line declined year over year as well. However, the company’s top line came almost in line with the consensus estimate after a miss in the previous quarter. Following the dismal bottom-line performance, shares of the company have lost 6.7% on Aug 10. In addition, management issued guidance for fiscal 2019, which fell shy of analysts’ expectations.
FOX SSP EVC MDPEB ETM.WI LMHA MDP TIME LMHB FOXA ETM LM

 
ETM / Entercom Communications Corp. FORM 10-Q (Quarterly Report)

2018-08-09 sec.gov
Form 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION
ETM

2
Entercom Communications Corp (ETM) CEO David Field on Q2 2018 Results - Earnings Call Transcript

2018-08-08 seekingalpha - 1
Good morning, and welcome to Entercom's Second Quarter 2018 Earnings Release Conference call. [Operator Instructions]. This conference is being recorded.
CBS CBS.A ETM.WI NYTAB CPV CBS.WD ETM

 
ETM / Entercom Communications Corp. FORM 8-K (Current Report)

2018-08-08 sec.gov
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ETM

 
Beasley Broadcast Group Second Quarter Earnings per Diluted Share Increases 28.6% to $0.18

2018-08-03 globenewswire
Conference Call and Webcast Today, August 3, 2018 at 10:30 a.m. ET 719/325-4768, conference ID 9601913 or www.bbgi.com Replay information provided below
BBGI ETM.WI ETM

 
Charter Communications (CHTR) Q2 Earnings & Revenues Beat

2018-08-01 zacks
Charter Communications Inc. (CHTR - Free Report) reported second-quarter 2018 adjusted earnings of $1.15 per share that beat the Zacks Consensus Estimate by 20 cents and surged 121.2% from the year-ago quarter. Revenues increased 4.8% year over year to $10.85 billion that beat the Zacks Consensus Estimate of $10.84 billion. Segment Details Residential revenues (79.8% of revenues) came in at $8.66 billion, up 4.
CHTR AMCX CMCSA ETM.WI TWC ETM

2
Zacks Industry Outlook Highlights: AMC, Entercom, Sky and Entravision

2018-07-31 zacks
Chicago, IL – July 31, 2018 – Today, Zacks Equity Research discusses Broadcast Radio & TV, including AMC Networks, Inc (AMCX - Free Report) , Entercom Communications Corp (ETM - Free Report) , Sky Plc (SKYAY - Free Report) and Entravision Communications Corp (EVC - Free Report) .
EVC ALGN AMCX ETM.WI ETM

3
Broadcast Radio and Television Outlook: Modest Growth Picture

2018-07-31 zacks - 1
The Zacks Broadcast Radio and Television industry is primarily benefiting from higher spending on video advertising. Moreover, rate increases are driving distribution of revenues for industry participants. Television ad spending is also strong primarily due to higher political spending in the first-half of 2018. As a series of contests are scheduled for November, the momentum in political spending is expected to remain strong.
EVC ALGN AMCX ETM.WI ETM

29
Beauty Lies In The Eye Of The Investor - Cramer's Mad Money (7/19/18)

2018-07-20 seekingalpha - 3
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Thursday, July 19.
ABT IBM FOX SQ UNP CMCSA DXCM MA PYPL ETM.WI ETM NUE ATRC LOB V FIVE AA

13
Funko, GTT, Netflix, Microsoft and Skyworks as Zacks Bull and Bear of the Day

2018-07-16 zacks
Chicago, IL – July 16, 2018 – Zacks Equity Research highlights Funko (FNKO - Free Report) as the Bull of the Day and GTT Communications (GTT - Free Report) as the Bear of the Day. In addition, Zacks Equity Research provides analysis on Netflix, Inc. (NFLX - Free Report) , Microsoft Corp. (MSFT - Free Report) and Skyworks Solutions, Inc. (SWKS - Free Report) .
RM AMC NFLX ETM.WI FITBI ETM SWKS MTCH ROSEU GTT FNKO MSFT FITB PAA NMM ROSE

61
Wells Fargo, JPMorgan, Bank of America, Goldman Sachs and Morgan Stanley are part of Zacks Earnings Preview

2018-07-16 zacks - 1
Chicago, IL – July 16, 2018 – Zacks.com releases the list of companies likely to issue earnings surprises. This week’s list includes Wells Fargo (WFC - Free Report) , JPMorgan (JPM - Free Report) , Bank of America (BAC - Free Report) , Goldman Sachs (GS - Free Report) and Morgan Stanley (MS - Free Report) .
WFCNP RM FITBI ETM BAC MTCH ROSEU MS PAA NMM ROSE WFC BAC AMC ETM.WI GTT FITB

12
Zacks Industry Outlook Highlights: Waters, Mettler-Toledo and PerkinElmer

2018-07-16 zacks
Chicago, IL – July 16, 2018 – Today, Zacks Equity Research discusses Outsourcing, including Waters Corporation (WAT - Free Report) , Mettler-Toledo International (MTD - Free Report) and PerkinElmer (PKI - Free Report) .
RM WSBF AMC WSCC ETM.WI FITBI ETM MTCH ROSEU GTT WAT FITB PAA PKI NMM ROSE

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to ETM / Entercom Communications Corp. on message board site Silicon Investor.

MeetMe, Inc. MeetMe, Inc. MeetMe, Inc. NetManage is going through the roof! NetManage is going through the roof! NetManage is going through the roof!
PetMed Express, Inc. (PETS) PetMed Express, Inc. (PETS) PetMed Express, Inc. (PETS) American Wagering (BETM) American Wagering (BETM) American Wagering (BETM)
American Wagering (BETM) American Wagering (BETM) American Wagering (BETM) NETM: Whats the BEEF? NETM: Whats the BEEF? NETM: Whats the BEEF?
USAI, 61% stake in Ticketmaster Online-CitySearch IPO USAI, 61% stake in Ticketmaster Online-CitySearch IPO USAI, 61% stake in Ticketmaster Online-CitySearch IPO PETM - Petsmart PETM - Petsmart PETM - Petsmart
ProTrader Securities and gr8tradeTM ProTrader Securities and gr8tradeTM ProTrader Securities and gr8tradeTM NetManage [NASDAQ: NETM]: Rebirth of a Pioneer NetManage [NASDAQ: NETM]: Rebirth of a Pioneer NetManage [NASDAQ: NETM]: Rebirth of a Pioneer
CUSIP: 293639100